Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/05/2009 | WO2009028625A1 Method of binding protein to support using tamavidin |
03/05/2009 | WO2009028582A1 Transformants capable of producing isopropanol |
03/05/2009 | WO2009028581A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
03/05/2009 | WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
03/05/2009 | WO2009028531A1 Docrine polypeptide and method of purifying recombinant fused protein using the same |
03/05/2009 | WO2009028521A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis |
03/05/2009 | WO2009028421A1 Transfection device utilizing sericin |
03/05/2009 | WO2009028418A1 Cyclosporin a-binding protein |
03/05/2009 | WO2009028345A1 Dimer amidite for synthesis of nucleic acid, nucleic acid synthesis method |
03/05/2009 | WO2009028338A1 Novel oxidase gene and method of producing 3-indole-pyruvic acid using the gene |
03/05/2009 | WO2009028319A1 Peptide derived from ephb6 mutant capable of binding to hla-a24 or hla-a2 molecule |
03/05/2009 | WO2009028294A1 Mutant lipase and use thereof |
03/05/2009 | WO2009028253A1 Peptide production method |
03/05/2009 | WO2009028218A1 Detection of bacteria belonging to the genus campylobacter targeting cell expansion lethal toxin |
03/05/2009 | WO2009027978A1 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS |
03/05/2009 | WO2009027830A2 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
03/05/2009 | WO2009027572A1 Use of active recombinant chymosin |
03/05/2009 | WO2009027539A2 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
03/05/2009 | WO2009027527A2 Rna antagonist compounds for the modulation of fabp4/ap2 |
03/05/2009 | WO2009027507A2 Aptamers which bind to a target molecule involved in haemostasis |
03/05/2009 | WO2009027495A1 Method for manufacturing a modified peptide |
03/05/2009 | WO2009027471A1 Methods for increasing protein titers |
03/05/2009 | WO2009027412A1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
03/05/2009 | WO2009027351A1 Plasmid production and expression of recombinant proteins in cells cultivated without antibiotics |
03/05/2009 | WO2009027335A2 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants |
03/05/2009 | WO2009027313A2 Pathogen control genes and methods of use in plants |
03/05/2009 | WO2009026892A1 Oligonucleotides for the inhibition of mouse major satellite sequences |
03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
03/05/2009 | WO2009026660A1 Dendritic cell marker and uses thereof |
03/05/2009 | WO2009026653A1 Neuroplasticity assay |
03/05/2009 | WO2009012384A3 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 |
03/05/2009 | WO2009012382A3 Compositions, kits, and methods for the modulation of immune responses using galectin-1 |
03/05/2009 | WO2009009589A3 System and methods for normalizing data in nucleic acid amplification procedures |
03/05/2009 | WO2009006584A3 Methods and compositions for identifying cellular rna transcripts |
03/05/2009 | WO2009006300A3 Production cell lines for adenoviral manufacturing |
03/05/2009 | WO2009005564A3 Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same |
03/05/2009 | WO2009004575A3 Cartilage-specific expression |
03/05/2009 | WO2009003676A8 Method for the generation of a non-human animal with an oncogene |
03/05/2009 | WO2009003178A3 Reagents and methods for cyanobacterial production of bioplastics and biomaterials |
03/05/2009 | WO2009001135A3 Combinatorial libraries and related methods |
03/05/2009 | WO2008156661A3 BACTERIAL MEDIATED TNF-α GENE SILENCING |
03/05/2009 | WO2008155120A3 Methods and compositions for treating mucositis |
03/05/2009 | WO2008153903A3 Heterologous and homologous cellulase expression system |
03/05/2009 | WO2008153676A3 Pentose phosphate pathway and fermentation enzyme-encoding nucleotide sequences with refined translational kinetics and methods of making same |
03/05/2009 | WO2008152523A9 Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof |
03/05/2009 | WO2008150892A3 Compositions for production of soybean with elevated oil content |
03/05/2009 | WO2008148845A3 Method of preparing a dough-based product |
03/05/2009 | WO2008148831A3 Antigen presenting cells |
03/05/2009 | WO2008142034A3 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
03/05/2009 | WO2008141308A3 Gene expression and pain |
03/05/2009 | WO2008137881A3 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
03/05/2009 | WO2008130372A3 Production of sterols in oleaginous yeast and fungi |
03/05/2009 | WO2008126083A3 Methods for identification and selection of human embryonic stem cell derived cells |
03/05/2009 | WO2008125222A3 New modulation molecules for an improved regulated expression system |
03/05/2009 | WO2008118957A3 Methods for modulating embryonic stem cell differentiation |
03/05/2009 | WO2008109531A4 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof |
03/05/2009 | WO2008109520A3 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
03/05/2009 | WO2008109375A3 Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof |
03/05/2009 | WO2008104974A3 Composition and methods for modulating cell proliferation and cell death |
03/05/2009 | WO2008095192A8 Gene silencing by single-stranded polynucleotides |
03/05/2009 | WO2008087562A3 Methods and compositions for modulating the mirna pathway |
03/05/2009 | WO2008066752A3 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
03/05/2009 | WO2008054713A3 Tissue specific gene therapy treatment |
03/05/2009 | WO2005094355A3 Methods for altering protein production rates |
03/05/2009 | US20090064376 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
03/05/2009 | US20090064375 Paraquat Resistance Gene and a Vascular Tissue- and Trichome-specific Promoter |
03/05/2009 | US20090064374 Expression cassettes for seed-preferential expression in plants |
03/05/2009 | US20090064373 Plants with altered root architecture, related constructs and methods involving genes encoding nucleoside diphosphatase kinase (ndk) polypeptides and homologs thereof |
03/05/2009 | US20090064372 Transformed Plant Expressing a Dextransucrase and Synthesizing a Modified Starch |
03/05/2009 | US20090064371 Methods for Increasing the Resistance of Plants to Hypoxic Conditions |
03/05/2009 | US20090064370 Habanero pepper hybrid px11423487 |
03/05/2009 | US20090064369 Habanero pepper hybrid px11423486 |
03/05/2009 | US20090064368 Watermelon line was146-4197 |
03/05/2009 | US20090064367 Tomato line chd 15-2062 |
03/05/2009 | US20090064366 Squash line zgn 130-1041t |
03/05/2009 | US20090064365 Squash line ycn 130-1053t |
03/05/2009 | US20090064364 Squash line ypc 130-1035t |
03/05/2009 | US20090064363 Pumpkin line hwn 130-1039t |
03/05/2009 | US20090064362 Pumpkin line hwn 130-1018t |
03/05/2009 | US20090064353 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines |
03/05/2009 | US20090064352 Creating poultry and other animals resistant to viral disease |
03/05/2009 | US20090064351 Transgenic bird producing erythropoietin and method of constructing the same |
03/05/2009 | US20090062543 Uv excitable fluorescent energy transfer dyes |
03/05/2009 | US20090062229 Method and composition for reducing the expression of rock-ii |
03/05/2009 | US20090062228 piRNA and uses related thereto |
03/05/2009 | US20090062226 Method and Compositions for Inhibiting MAGE Protein Interaction With KAP-1 |
03/05/2009 | US20090062225 Double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of one of the genes of the JC virus and the use of the dsRNA to treat pathological processes mediated by JC virus infection, such as PML; sense, antisense |
03/05/2009 | US20090062207 Methods and compositions for the treatment of gastrointestinal disorders |
03/05/2009 | US20090062199 Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
03/05/2009 | US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B) |
03/05/2009 | US20090062189 Tumor suppressor protein and nucleotide encoding same |
03/05/2009 | US20090062188 Disease-Associated Protein |
03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
03/05/2009 | US20090062148 Substrate preparation process |
03/05/2009 | US20090062147 Methods for synthesis of encoded libraries |
03/05/2009 | US20090062143 Translation initiation region sequences for optimal expression of heterologous proteins |
03/05/2009 | US20090062142 Methods for enhancing bacterial cell display of proteins and peptides |
03/05/2009 | US20090062139 Phytases, nucleic acids encoding them and methods for making and using them |
03/05/2009 | US20090062137 Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases |